TuHURA Biosciences, Inc. (HURA)
Last updated: 2026-10-21 01:10:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
TuHURA Biosciences, Inc. (HURA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.77, with a market capitalization of $112.16M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.41 to $3.43. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$112.16M | |
$1.77 | |
$7.93 | |
$0.41 | |
$1.78 | |
35.57K | |
222.97K | |
-- | |
$3.43 | |
$0.41 | |
0.01% | |
-- |
TuHURA Biosciences, Inc. (HURA) Latest Closing Stock Price
TuHURA Biosciences, Inc. (HURA) last closed at $1.78 as of 2026-10-20 23:31:00, unchanged from the previous close of $1.78.
During the latest regular trading session, HURA traded between $0.41 and $7.93, with a volume of 35.57K shares. The closing price was near the lower end and near the middle of its 52-week range.
TuHURA Biosciences, Inc. (HURA) 7-Day Stock Price Change
Over the past seven days, TuHURA Biosciences, Inc. (HURA) moved from $1.96 to $1.77, representing a decline of 9.95% ($0.20).
The stock traded between $1.71 and $1.99 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 166.48 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
HURA 52-Week Price Position
Position in Range: 44.9%
HURA is currently trading at $1.77, placing it 44.9% of the way from its 52-week low of $0.41 to its 52-week high of $3.43. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is TuHURA Biosciences, Inc. (HURA)?
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
TuHURA Biosciences, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 22 |
| Exchange | NASDAQ |
| Company Website |
How to Buy TuHURA Biosciences, Inc. (HURA) Stock on MEXC
Eligible investors can buy real shares of TuHURA Biosciences, Inc. (HURA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is TuHURA Biosciences, Inc. (HURA) stock price today?
2.Is HURA stock going up or down today?
3.What is HURA pre-market price?
4.What is HURA after-hours price?
5.Is HURA stock trading now?
6.Where does HURA sit relative to its 52-week high and low?
7.What sector is TuHURA Biosciences, Inc. in?
8.What is TuHURA Biosciences, Inc.'s market capitalization and where is it listed?
9.How is HURA valued in terms of P/E ratio and EPS?
10.Does TuHURA Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
HURA Stock Calculator
Estimate the value between HURA shares and USD.
HURA Shares to USD
1.00 HURA shares = 1.765 USD
Calculations are estimates based on the latest available price and are for reference only.


